By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > News > Arkema Stock: Entering Oversold Territory (OTCMKTS:ARKAF)
News

Arkema Stock: Entering Oversold Territory (OTCMKTS:ARKAF)

News Room
Last updated: 2023/06/10 at 11:21 PM
By News Room
Share
8 Min Read
SHARE

Global specialty materials company Arkema SA (OTCPK:ARKAY) (OTCPK:ARKAF) has been punished this year amid fading China reopening hopes, as well as weakness across its key end markets. While Q1 outpaced a low bar, helped by relatively resilient results across its core divisions, the stock remains well off last year’s highs and, perhaps more importantly, has underperformed the broader French index (up mid-teens% over the last year). With the valuation now down to ~5x EV/EBITDA (~4x fwd), however, Arkema may be entering oversold territory. Besides delivering on its organic growth potential, the company is still levered to secular ESG themes like electric vehicle batteries, while its strong balance sheet allows for compelling M&A optionality. Expect more acquisitions like Ashland’s (ASH) Performance Adhesives unit (+2.2%pts contribution to Q1 2023 sales) in the coming years as management accelerates the transition into a pure-play specialty materials unit. And as the battery destocking cycle enters its final stages, investors willing to stick it out for a few quarters stand to be well rewarded, in my view. The well-covered ~4% yield means investors also get paid to wait.

Contents
Few Surprises as the Cyclical Downtrend Continues in Q1Reaffirmed Guidance Implies a Better H2 AheadLong-Term Growth Intact Despite the Near-Term HeadwindsEntering Oversold Territory
Chart
Data by YCharts

Few Surprises as the Cyclical Downtrend Continues in Q1

Arkema unsurprisingly reported another quarter of declining volumes across its core businesses, with the demand weakness from last year extending into Q1 2023 as well. Slower Europe construction activity was the main detractor, along with a slowdown in the US. By segment, adhesive solutions (28% sales contribution) was the outperformer at +4.2% revenue growth, helped by a +6.7% YoY price hike (-12.7% volumes; +10.0% scope from Ashland’s adhesives). A favorable mix shift towards more value-added solutions (“high-performance adhesive applications”) was the key revenue driver, helped by further synergy benefits from the Ashland Adhesive unit acquisition (integration on track with Arkema targets).

Elsewhere, the advanced materials segment saw a high-single-digit % price hike as well, though a 20.5% YoY decline in volumes more than offset any pricing gains. Like the >20% drop in volumes for the coating solutions segment, however, the headwinds were mostly related to temporary destocking activity in key end markets like Chinese batteries and should improve over time. Also weighing on volumes in advanced materials was the lack of a China reopening boost (recall management had previously hoped for some uplift in H1). As a result, overall EBITDA was down >40% YoY (~6.9%pt swing in margins to 14.5%), though the EUR367m in Q1 was still ahead of a low consensus bar.

Q1 2023 P&L Highlights

Arkema SA

Reaffirmed Guidance Implies a Better H2 Ahead

Arkema expects some reprieve from the macro weakness in Q2, though a meaningful upturn is only guided to kick in from H2 onward. Still, the company has kept full-year EBITDA guidance within the EUR1.5-1.6bn range (assuming no unforeseen macro disruptions ahead) and a relatively high EBITDA conversion ratio of >40%. The assumptions underlying this view seem reasonable – for instance, management expects the Chinese battery destocking cycle to wind down by H2 before a restocking cycle begins later in the year to boost volumes. Also in the pipeline are potentially high-return projects such as the polyvinylidene fluoride (abbreviated to PVDF, a key input for lithium-ion batteries due to its thermal stability and adhesive properties) capacity expansion in China and France. Alongside the ongoing Polyamide 11 capacity expansion in Singapore and Sartomer photocure resins capacity expansion in China, the EUR50-70m incremental EBITDA benefit (up to EUR200m at maturity) poses upside to the full-year numbers.

Expansion Projects

Arkema SA

Another potential source of near-term upside is raw material costs. As management outlined in its outlook statement, costs have been easing for some time now, along with energy prices (though sanctions have kept these relatively high in Europe). The post-Q1 path for energy prices appears to be to the downside – aggregate demand in Europe remains weak, as economic growth has slowed amid an extended ECB monetary tightening cycle and elevated consumer inflation. The US is relatively better positioned on growth and inflation, but recent PMI reports indicate its manufacturing activity is slowing. Also weighing on energy prices is the lack of a meaningful ex-consumption rebound in China, though management expects a broader recovery in H2, along with the end of its battery destocking cycle. Alongside supply-side headwinds (e.g., oil-producing nations like Russia and Nigeria have pushed back on cuts at last week’s OPEC+ meeting, while the UAE will be raising output), any near-term volume weakness could well be offset by easing cost pressures at the EBITDA line.

Long-Term Growth Intact Despite the Near-Term Headwinds

Since outlining its long-term goal of transitioning into a higher-margin specialty chemical materials company in 2020, the company has made several positive steps, including non-core divestments, to rebalance its portfolio. As of 2022, specialty materials now contribute 91% of business revenue (vs. 79% in 2019), but with margin expansion still in its early stages (18.1% margin for specialty materials vs. 30% for intermediates), the earnings growth runway remains extensive.

Segment Overview

Arkema SA

Backed by a strong balance sheet and ample M&A optionality following the YTD de-rating in the space, Arkema should easily complete the transition in 2024. The question from here is where margins eventually land once scale benefits fully kick in. With Arkema’s recent acquisitions placing the company in a better position to capture the electrification tailwind globally (accelerated by US and EU policies), I see more upside than downside over the long run. But in the meantime, the company will need to navigate the cyclical downturn amid global demand weakness and destocking in China. Pending visibility into an H2 recovery and China’s reopening broadening out beyond consumption, investor sentiment is likely to stay downbeat, presenting long-term patient investors with a compelling entry point at ~4x fwd EV/EBITDA and ~9x fwd P/E.

Entering Oversold Territory

Arkema closed out Q1 stronger than expected, with resilient results across its core divisions pushing EBITDA over consensus expectations. Progress on unlocking post-acquisition synergies from Ashland’s (Performance Adhesives unit) has also been encouraging. Equipped with ample liquidity to ride out the near-term volatility, along with more balance sheet headroom for M&A, the company looks poised to deliver on its long-term strategic shift toward specialty chemicals. While near-term headwinds from destocking and global demand weakness are material, the stock has likely priced in these negatives at ~4x EBITDA. Alongside the low valuation bar, investors also get a well-covered low to mid-single-digit % dividend yield; hence, the risk/reward on Arkema screens attractively here.

Editor’s Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.

Read the full article here

News Room June 10, 2023 June 10, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Trump’s patience with Netanyahu is running out

Unlock the White House Watch newsletter for freeYour guide to what Trump’s…

Energy groups scrap Texas-backed projects as costs rise

Stay informed with free updatesSimply sign up to the Oil & Gas…

Spain probes cyber weaknesses at small power plants after blackout

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

Surge in Chinese listings drives boom for US small-cap IPO market

Unlock the White House Watch newsletter for freeYour guide to what Trump’s…

Republicans present plans to gut US support for clean energy

Unlock the White House Watch newsletter for freeYour guide to what Trump’s…

- Advertisement -
Ad imageAd image

You Might Also Like

News

Trump’s patience with Netanyahu is running out

By News Room
News

Energy groups scrap Texas-backed projects as costs rise

By News Room
News

Spain probes cyber weaknesses at small power plants after blackout

By News Room
News

Surge in Chinese listings drives boom for US small-cap IPO market

By News Room
News

Republicans present plans to gut US support for clean energy

By News Room
News

Proxy adviser ISS backs Elliott in fight against Phillips 66

By News Room
News

Saudi Arabia launches AI venture Humain ahead of Donald Trump visit

By News Room
News

Perplexity nears second fundraising in six months at $14bn valuation

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?